Heart Test Net Worth
Heart Test Net Worth Breakdown | HSCSW |
Heart Test Net Worth Analysis
Heart Test's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Heart Test's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Heart Test's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Heart Test's net worth analysis. One common approach is to calculate Heart Test's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Heart Test's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Heart Test's net worth. This approach calculates the present value of Heart Test's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Heart Test's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Heart Test's net worth. This involves comparing Heart Test's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Heart Test's net worth relative to its peers.
To determine if Heart Test is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Heart Test's net worth research are outlined below:
| Heart Test is way too risky over 90 days horizon | |
| Heart Test has some characteristics of a very speculative penny stock | |
| Heart Test appears to be risky and price may revert if volatility continues | |
| Heart Test has high likelihood to experience some financial distress in the next 2 years | |
| Heart Test Laboratories has accumulated 2.99 M in total debt. Heart Test Laboratories has a current ratio of 0.58, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about Heart Test's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the revenue of 4.35 K. Net Loss for the year was (8.77 M) with profit before overhead, payroll, taxes, and interest of 2.47 K. | |
| Heart Test Laboratories has accumulated about 723.48 K in cash with (7.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.22, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Heart Test has a frail financial position based on the latest SEC disclosures | |
| Latest headline from MacroaxisInsider: Acquisition by Danielle Watson of 9000 shares of Heart Test at 3.33 subject to Rule 16b-3 |
Project Heart Test's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (3.36) | (3.53) | |
| Return On Capital Employed | (16.07) | (15.27) | |
| Return On Assets | (2.08) | (2.18) | |
| Return On Equity | (42.72) | (44.86) |
When accessing Heart Test's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Heart Test's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Heart Test's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Heart Test's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Heart Test Laboratories. Check Heart Test's Beneish M Score to see the likelihood of Heart Test's management manipulating its earnings.
Evaluate Heart Test's management efficiency
The company has return on total asset (ROA) of (0.7607) % which means that it has lost $0.7607 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.3304) %, meaning that it generated substantial loss on money invested by shareholders. Heart Test's management efficiency ratios could be used to measure how well Heart Test manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -3.53 in 2025. Return On Capital Employed is likely to climb to -15.27 in 2025. At this time, Heart Test's Total Current Assets are fairly stable compared to the past year. Intangible Assets is likely to climb to about 1.8 M in 2025, whereas Non Current Assets Total are likely to drop slightly above 1 M in 2025.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.22 | 0.23 | |
| Tangible Book Value Per Share | (1.50) | (1.43) | |
| Enterprise Value Over EBITDA | (0.64) | (0.67) | |
| Price Book Value Ratio | 16.05 | 15.25 | |
| Enterprise Value Multiple | (0.64) | (0.67) | |
| Price Fair Value | 16.05 | 15.25 | |
| Enterprise Value | 4.7 M | 4.1 M |
Leadership at Heart Test emphasizes sustainable growth and financial prudence. Our analysis evaluates how these priorities impact the stock's performance in the market.
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Heart Test insiders, such as employees or executives, is commonly permitted as long as it does not rely on Heart Test's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Heart Test insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Danielle Watson 3 days ago Acquisition by Danielle Watson of 9000 shares of Heart Test at 3.33 subject to Rule 16b-3 | ||
Mark Hilz over a week ago Disposition of 4416 shares by Mark Hilz of Heart Test at 3.5374 subject to Rule 16b-3 | ||
Bent Bruce over three weeks ago Acquisition by Bent Bruce of 6000 shares of Heart Test at 3.33 subject to Rule 16b-3 | ||
Danielle Watson over three weeks ago Acquisition by Danielle Watson of 25000 shares of Heart Test at 4.37 subject to Rule 16b-3 |
Heart Test Earnings per Share Projection vs Actual
Heart Test Corporate Executives
Elected by the shareholders, the Heart Test's board of directors comprises two types of representatives: Heart Test inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Heart. The board's role is to monitor Heart Test's management team and ensure that shareholders' interests are well served. Heart Test's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Heart Test's outside directors are responsible for providing unbiased perspectives on the board's policies.
Additional Tools for Heart Stock Analysis
When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.